neohepatect
biotest pharma gmbh - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
rhophylac
csl behring gmbh - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
keyvenb
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
niuliva
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
rhesonativ
octapharma italy s.p.a. - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
vebiked
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
kedhbs
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
stagloban p +ce
idt biologika gmbh - immunoglobulina da cane, anticorpi contro la parvovirosi, anticorpi contro il cimurro, virus inattivato dell' epatite infettiva del cane - immunoglobulina da cane - 170 mg; anticorpi contro la parvovirosi - 1 : 10000; anticorpi contro il cimurro - 5000 ui; virus inattivato dell' epatite infettiva del cane - 1000 ui - canine distemper antiserum + canine adenovirus antiserum + canine parvovirus antiserum
lymphoglobuline
sanofi b.v. - immunoglobulina equina antilinfocitaria - immunoglobulina equina antilinfocitaria
hizentra
csl behring gmbh - immunoglobulina umana normale (scig) - sindromi da immunodeficienza immunologica - sieri immuni e immunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.